CD8A and COVID-19: In an analysis of Ad26.COV2.S immunogenicity against COVID-19 variants of concern, while some reduction in neutralizing antibodies was seen for variants versus the prototype SARS-CoV-2 strain, the CD8+ and CD4+ T cell responses remained comparable against all strains [87].